Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

420 with CNW — California Governor Enacts Bill Regulating Medical Cannabis Use in Hospitals

Last week, Gov. Gavin Newsom signed a legislation that would require hospitals to allow some patients to use medical cannabis. The governor of California signed the bill, having revealed that his concerns about an initial version of the bill that he had vetoed had been resolved.

The sponsor of the legislation, Sen. Ben Hueso, has been advocating for the measure to allow marijuana use in health facilities for patients with terminal illnesses over multiple sessions. Recently, Hueso sent a letter to the head of U.S. Department of Health and Human Services asking for clarification on whether the change in policy would threaten federal funding for medical facilities that allowed for the plant’s use.

Confusion about the potential implications for allowing for the consumption of cannabis in medical facilities was what prompted Newsom’s veto decision in 2019. Representatives from the governor’s office as well as the Department of Health and Human Services reached out to the senator asserting that they were looking into the matter.

The senator also received a letter from the Centers for Medicare and Medicaid Services, which stated that there were no federal regulations that addressed this particular issue, noting that the agency was not aware of any cases where funds had been pulled because a medical facility permitted its patients to use medical marijuana. In a press release, Hueso stated that he was confident that medical facilities had the authority to implement the legislation’s provisions while ensuring the safety of other employees, guests and patients of the medical facility as they were in compliance state laws and had received confirmation from the safeguards in the law as well as the Centers for Medicare and Medicaid Services.

However, there are a few restrictions that are included in the new law. For instance, vaping and smoking cannabis will be prohibited, and patients who receive treatment for emergency care will not be covered. The law also stipulates that health facilities will not be mandated to dispense or provide marijuana.

Newsom did not release a statement about the hospital legislation, which the governor’s office revealed that he’d signed, along with other unrelated bills. The governor has yet to sign legislation that would establish a regulatory framework for CBD sales derived from hemp. The legislation would also lift the ban on smokable hemp products.

In other news, activists in California have received clearance to start gathering signatures for a ballot measure for 2022 that would legalize psilocybin mushrooms in the state.

Now that patients in California can use medical cannabis within hospitable premises, it would be eye-opening to assess how beneficial enabling devices such as the RYAH Smart Inhaler made by RYAH Group Inc. (CSE: RYAH) can be for those patients.

NOTE TO INVESTORS: The latest news and updates relating to RYAH Group Inc. (CSE: RYAH) are available in the company’s newsroom at https://cnw.fm/RYAH

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — What Could the Future Hold for the UK’s CBD Sector?

The past couple of years have seen cannabidiol (“CBD”), a hemp extract that’s said to be filled with potent medicinal properties, become immensely popular in several territories across the world. Most countries with legal CBD markets legalized the hemp extract within the past decade, and as a whole, the industry still hasn’t been properly regulated. The United Kingdom’s CBD market is underregulated and over restricted, mirroring the legislative situation in most CBD markets around the world. However, around 6 million people in the UK have used CBD in some form, and the market is poised for explosive growth as even more people turn to CBD thanks to its medical applications.

So what can industry stakeholders and consumers expect from the UK’s CBD market in the years to come? For starters, we will likely see legislative reform of some sort as the market grows. Underregulated as it is, the CBD market has attracted unscrupulous companies looking to make a quick buck without any regard for their customers’ health. Regulation would clean up the industry, getting rid of the unethical players and their products while legitimizing the young CBD industry and attracting customers who would have otherwise avoided CBD. The recent Novel Foods legislation was a great start in regulating and legitimizing the CBD sector.

We can also expect regulations for the marketing of CBD products. Currently, CBD firms cannot directly advertise their products to consumers, meaning public awareness of CBD is pretty low. As the CBD market becomes more regulated, we will most likely see marketing regulation reform that will finally allow CBD companies to market their products to the public. This would in turn increase public awareness and attract more customers. The recent brand campaign by Cannaray CBD featuring Claudia Winkleman is an example of what CBD marketing could evolve into.

Personalized consultation may also become the norm. Just as America’s state-legal cannabis sector has “budtenders” who will answer customer questions about cannabis, UK’s CBD space will likely see an increase in consultation-dependent retail. CBD is a mystery to many people, and even for thos who are aware of it, knowledge is limited. Consultation and real-life sales support will be integral to helping customers understand CBD and its potential risks and benefits. This could result in the development of a countrywide network of CBD experts, healthcare professionals, scientists and general practitioners.

Product innovation will also become the norm. By its very nature, the CBD space is quite innovative with companies constantly working to develop high-quality CBD products. As such, there are now innumerable CBD-infused products, including pet care products and clothing. As the industry develops and matures, and customers learn more about CBD and its benefits, we can expect more product innovation and an increase in retail sales.

A number of parallels can be drawn from the CBD sector in the United Kingdom in comparison to the market in North America where companies such as Simply Sonoma Inc. are currently operating.

NOTE TO INVESTORS: The latest news and updates relating to Simply Sonoma Inc. are available in the company’s newsroom at https://cnw.fm/Sonoma

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Achieves 13% QOQ Revenue Growth, Marks Remarkable Q2 2021

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) recently released its financial results for the second quarter of fiscal 2021. The company’s revenue was up 13% to $13.3 million, from $11.8 million in Q1 2021. In addition to a growth in revenue, RWB also received the Florida Department of Health, Office of Medical Marijuana Use approval; closed the acquisition of Acreage Florida; secured 20 double wide fully enclosed cultivation pods that will offer approximately 19,000 square feet of turn-key cultivation space; and completed the more comprehensive portion of Michigan’s two-step application process for medical marijuana licensing through its wholly owned operating subsidiary, RWB Michigan LLC. The company also closed the acquisition of an operational 45,000 SF greenhouse located on 4.7 acres of land in Apopka, Florida. Additionally, by the close of Q2 2021, RWB had completed over $52 million in financing transactions, retiring at least $7.7 million in debt. A recent article reads, “Q2 2021 was remarkable for RWB. Fiscal performance was impressive, and the company also made some strategic decisions and investments that guarantee its growth in performance as time progresses. The company is confident and optimistic about its performance in Q3 as well as the second half of 2021.”

To view the full article, visit https://cnw.fm/65fus

About Red White & Bloom Brands Inc.

The company is positioning itself to be one of the top three multistate cannabis operators active in the U.S. legal cannabis and hemp sector. RWB is predominantly focusing its investments on the major U.S. markets, including Michigan, Illinois, Florida, Massachusetts, Arizona and California with respect to cannabis, and the U.S. and internationally for hemp-based CBD products. For more information about the company, visit www.RedWhiteBloom.com.

NOTE TO INVESTORS: The latest news and updates relating to RWBYF are available in the company’s newsroom at https://cnw.fm/RWBYF

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Alkaline88 Available in Sam’s Club This Fall

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER), the country’s largest independent alkaline water company, has announced that Sam’s Club will carry its Alkaline88(R) single-serve, one-Liter 12-pack offering in all 587 locations in the continental U.S. The product will be available by early November. The company stated that the agreement was possible because of its increased supply chain and production capabilities, including four new co-packers working to support WTER’s expected increase in volume. The single-serve, one-liter is the first of WTER’s products available in the all-important club channel, but the company hopes more of its offerings will follow. A leading membership warehouse club with nearly 600 clubs and millions of members in the United States and Puerto Rico, Sam’s Club offers a milestone moment for the company. “Alkaline88’s presence in Sam’s Club marks another milestone for our company and its stockholders,” said The Alkaline Water Company president and CEO Ricky Wright in the press release. “Sam’s Club is known for offering superior products and savings to their members. They are one of the largest membership warehouse clubs with millions of members nationwide. Beginning in November, members will find Deliciously Smooth(TM) Alkaline88 one-liters in a convenient 12-pack in their local Sam’s Club. The increased sales of our single serves this fiscal year will accelerate even more with this major win.” To view the full press release, visit https://cnw.fm/pE6kD About The Alkaline Water Company Founded in 2012, The Alkaline Water Company is headquartered in Scottsdale, Arizona. Its flagship product, Alkaline88(R), is a leading premier alkaline water brand available in bulk and single-serve sizes along with eco-friendly aluminum packaging options. With its innovative, state-of-the-art proprietary electrolysis process, Alkaline88(R) delivers perfect 8.8 pH balanced alkaline drinking water with trace minerals and electrolytes and boasts the company’s trademarked Clean Beverage label. Quickly recognized as a growing lifestyle brand, Alkaline88 created the A88 Infused(TM) Beverage Division in 2018 to meet consumer demand for flavor-infused products under the A88 Infused brand. A88 Infused(TM) flavored water is available in six unique all-natural flavors, with new flavors coming soon. The Alkaline Water Company was pleased to welcome Shaquille O’Neal to its board of advisors and to serve as the celebrity brand ambassador for the Alkaline88 and A88 Infused brands. To learn more about the company, please visit www.Alkaline88.com and www.TheAlkalineWaterCo.com. NOTE TO INVESTORS: The latest news and updates relating to WTER are available in the company’s newsroom at http://cnw.fm/WTER About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer Do you have questions or are you interested in working with CNW? Ask our Editor CannabisNewsWire (CNW) Denver, Colorado www.CannabisNewsWire.com 303.498.7722 Office Editor@CannabisNewsWire.com CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces Launch of Global Clinical Trials

Flora Growth Corp. (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, has announced its entry into an agreement to begin scientific clinical trials globally. According to the update, the focus of this study will be on the use of cannabinoids in patients suffering from fibromyalgia or chronic pain, with primary research sites located in the United States and the United Kingdom. By running phase trials in parallel (in vitro, in vivo, pilot in human, safety/efficacy, etc.), Flora Pharma expects to fast track traditional FDA and NHS timelines. “A paradigm shift is upon us where health care practitioners, researchers, patients and adult-use consumers are starting to understand, accept and embrace the therapeutic potential offered by phytocannabinoid-based medicine. As such, there is an urgent need for more research to better understand the molecular and biochemical effects of cannabis at the cellular level, to begin to apply its implications as a pharmaceutical drug,” said Dr. Annabelle Manalo-Morgan, director and lead scientific advisor of Flora Growth. “I’m extremely pleased that our team recognizes the importance and necessity of this research, not only to create and bring to market novel pharmaceutical cannabis products for patients around the world that are more efficacious and have a superior safety profile compared to traditional and incumbent pharmaceutical treatment options, but to also enhance long-term shareholder value. While this may seem like an ambitious and costly endeavor, we will be able to leverage our seed-to-sale platform to supply products for research and commercialization at incredibly favorable and competitive price points, while partnering with established organizations and institutions where additional funding subsidies are available.”

To view the full press release, visit https://cnw.fm/S1Vvl

About Flora Growth Corp.

Flora is a cannabis company that leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its diverse business divisions of cosmetics, hemp textiles, and food and beverage. As the operator of one of the largest outdoor cultivation facilities, Flora strives to market a higher-quality premium product at below-market prices. By prioritizing natural ingredients and value-chain sustainability across its portfolio, Flora creates premium products that help consumers restore and thrive. Visit www.FloraGrowth.ca or follow @floragrowthcorp on social for more information.

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://cnw.fm/FLGC

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — State Departments of Agriculture Demand Expansion of Federal Hemp Cultivation Grants

More than six years after hemp pilot programs were launched by the 2014 Farm Bill, the nascent sector is still plagued by patchwork state legislations and little if any federal regulation. As more farmers dip their toes into the hemp space and it becomes more lucrative, industry players and lawmakers alike have consistently urged the U.S. Department of Agriculture (“USDA”) to craft standardized hemp rules. Now, the National Association of State Departments of Agriculture (“NASDA”) is asking the USDA to expand hemp farmers’ access to federal grants by allowing for two different classifications based on its intended use.

This comes a week after members of the NASDA, which represents agriculture departments in all 50 states and four U.S. territories, agreed during an annual meeting to change the organization’s policy regarding USDA’s Specialty Crop Block Program. The organization is now requesting that the USDA allow hemp farmers to designate their crops as either an agronomic commodity or a specialty crop. If the USDA agrees to this request, it would help farmers across the country have expanded access to federal grants, providing them with the valuable resources they need to prosper in the evolving hemp space, stakeholders say.

NASDA’s new policy states that the organization supports dual designation for hemp as a specialty crop based on the way and the purpose for which it is grown as well as expanding eligibility to funding from Specialty Crop Block Grant Program to include farmers who grow hemp for horticultural purposes. According to Jonathan Miller, general counsel for the U.S. Hemp Roundtable, the group is encouraged by NASDA’s commitment to working with the hemp industry and identifying solutions that support hemp farmers. The move also has the potential to open the door to the finding and support that hemp farmers “desperately need,” especially as the country struggles to recover from the coronavirus pandemic.

In a press release, NASDA CEO Barb Glenn said allowing hemp to be designated as both a specialty crop and agronomic commodity acknowledges the plant’s “up and coming nature” and assures new farmers that they will be supported if regardless of which route they choose — growing hemp for fiber, food or horticultural use. Herrick Fox, the co-chair of the National Industrial Hemp Council’s government relations committee, posits that the only reason hemp wasn’t granted dual designation by the USDA before is because federal agencies are still getting used to the idea of hemp being legal after nearly a century of prohibition.

Fortunately, the USDA is now working to create a regulatory structure for hemp. The agency passed a Final Rule on hemp earlier this year, and the agency is about to run a large-scale survey to gain a deeper understanding of the hemp sector.

If the federal grant program is expanded for hemp farmers, the additional sources of hemp biomass for manufacturing entities such as Golden Triangle Ventures Inc. (OTC: GTVH) could significantly expand since farmers would be able to grow the plant on larger tracts of land.

NOTE TO INVESTORS: The latest news and updates relating to Golden Triangle Ventures Inc. (OTC: GTVH) are available in the company’s newsroom at https://cnw.fm/GTVH

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — What Are Cannabidiol Crystals?

Cannabis has become popular in the last few years, as more states across the country legalize it for both recreational and medical use. The plant has more than 100 compounds, with roughly 80 of them being classified as cannabinoids. CBD is one of the two main cannabinoid compounds found in the marijuana plant; the other one is THC, which has psychoactive properties that induce a marijuana high. THC is found in high concentrations in most cannabis strains.

CBD, or cannabidiol, has numerous potential health benefits. In its pure form, CBD is known as CBD isolate or CBD crystals. Below, we explore what CBD crystals are and how they can be used.

What are CBD crystals?

These crystals only contain CBD, which can be extracted in multiple ways from the marijuana plant. These methods include solvent extraction, carbon dioxide extraction and steam distillation. The end product usually contains different compounds from the marijuana plant, including low THC levels. However, this is dependent on the plant source.

At this stage, the extracted CBD is either broad spectrum or full spectrum. It is at this stage that the product is further refined to get CBD isolate.

The refining process used to obtain CBD crystals removes all non-CBD compounds from the product, leaving behind pure CBD in crystal form. These crystals can then be used in other CBD products or ground up and sold.

What is the difference between CBD isolate and other CBD forms?

CBD isolate doesn’t contain THC. This is in addition to having no distinct smell or flavor, because it’s highly refined.

What are its benefits?

While studies on CBD are still in their early stages, researchers believe that cannabidiol influences cannabinoid receptors in the human body. The potential health benefits of this compound include:

Pain relief
Anti-anxiety effects
Anti-seizure effects
Nausea relief
Vomiting prevention
Anti-inflammation effects
Immune-boosting properties

A recently published article also found that CBD may impact noncannabinoid receptors such as the 5-HTP serotonin receptor. Serotonin is the chemical produced by the brain and has an effect on sleep and is known to influence an individual’s levels of depression and anxiety. This may explain why some individuals report that CBD has positively affected their symptoms of anxiety and pain.

How are CBD crystals used?

The compound can be used in various ways, including dissolving them into a carrier oil such as olive oil and jojoba oil; using it in DIY skin-care formulations; or adding the crystals to baked foods and goods. CBD isolate needs to be dissolved in butter or oil before it can be added to food.

Given the limitations of CBD crystals, including the absence of an entourage effect triggered by other hemp compounds, leading companies such as The Alkaline Water Company Ltd. (NASDAQ: WTER) (CSE: WTER) prefer to use broad-spectrum and full-spectrum CBD in their products.

NOTE TO INVESTORS: The latest news and updates relating to The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) are available in the company’s newsroom at http://cnw.fm/WTER

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Golden Triangle Ventures Inc. (GTVH) Releases Preliminary Results Showing HyGrO Technology Could Increase Longevity of Cut Flowers

Golden Triangle Ventures (OTC: GTVH) released the successful results of preliminary testing of its proprietary HyGrO hydrogen water technology and is looking forward to pursuing larger-scale studies. The company will work with commercial-scale flower products to further evaluate the efficacy of GTVH’s new process. The preliminary research, which lasted 21 days, was designed to assess whether hydrogen-infused water via the HyFrontier Technologies HyGrO system would increase the longevity of cut flowers, including stock roses, carnations and gladiolas. “Two vases were filled, one with regular tap water and one with HyGrO water. The water was never changed, and pictures were taken to document the results,” explains a recent article. “From the results, photos and observations made in this study, the company concluded that water produced using HyGrO’s patent-pending technology could increase the shelf life of cut flowers, reduce the bloom rate and potentially reduce waste in the floral industry. Plans are already underway to confirm the results through a larger study.”

To view the full article, visit https://cnw.fm/GB4Vj

About Golden Triangle Ventures Inc.

Golden Triangle Ventures is a multifaceted consulting company pursuing ventures in the health, entertainment and technology industries, with many additional projects being developed that provide synergistic values to these divisions. The company aims to purchase, acquire and/or joint venture with established entities that management can help assist and develop into unique opportunities. Additionally, GTVH provides a professional corporate representation service to different companies in these sectors while consulting on a variety of business development objectives. The goods and services represented are driven by innovators who have passion and commitment to these marketplaces. The company plans to utilize relationships and create a platform for new and existing businesses to strengthen their products and/or services. The three points of the Golden Triangle exclusively represent these three sectors in which the company aims to do business. For more information, visit the company’s website at www.GoldenTriangleInc.com.

NOTE TO INVESTORS: The latest news and updates relating to GTVH are available in the company’s newsroom at https://cnw.fm/GTVH

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Cannabis Strategic Ventures (NUGS) Launches LA Dispensary Brand, Announces Cultivation Expansion

Cannabis Strategic Ventures (OTCQB: NUGS), an emerging leader in the U.S. cannabis marketplace, is beginning to deploy its licenses; that process includes the opening of the first Los Angeles location of MDRN (“MDRN”) Tree, the company’s customer-facing dispensary brand. After the opening of its LA location, NUBS anticipates utilizing another of its new licenses to establish an indoor cultivation facility. With up to 1,200 grow lights, the facility is expected to product two to three pounds of premium exotic cannabis flower per light per harvest, with the company projected an average of 5.75 harvests per year. Based on that production, NUGS is estimated the potential for total production capacity of more than 15,000 pounds of premium exotic cannabis flower per year. “After securing key licensing, we are wasting no time in deploying those assets to launch one of California’s top vertical cannabis models,” said Cannabis Strategic Ventures CEO Simon Yu in the press release. “MDRN Tree will be our factory retail store — our direct interface with our end-market community — where we plan on showcasing the cannabis flower produced at our NUGS Farm North cultivation site. This farm-to-sale model offers the potential to drive simultaneous gains in quality control and profitability, and I look forward to providing further updates as we make strides in this direction.”

To view the full press release, visit https://cnw.fm/SMtXv

About Cannabis Strategic Ventures

Cannabis Strategic Ventures is one of the largest publicly traded marijuana cultivators in the United States. The company is based in Los Angeles and incubates, develops and partners with category leaders within the cannabis and ancillary sectors. The firm’s NUGS brand experience provides operational and financial strategic partnerships and a range of essential services to emerging and existing cannabis consumer brands.

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Outstanding Results of Oral Nicotine Study

Lexaria Bioscience Corp. (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that its recent oral nicotine absorption study NIC-A21-1 revealed that DehydraTECH(TM)-nicotine delivered via the oral pouch product format required only two to four minutes to deliver nicotine levels in blood plasma comparable to levels achieved at 45 minutes with concentration-matched controls. In addition, DehydraTECH-nicotine reached statistically significant peak blood plasma levels up to 10-fold higher overall than controls (p=0.004) while still clearing from blood virtually as quickly as the controls. “We are extremely pleased with the performance of our latest DehydraTECH-2.0 nicotine oral pouch formulations in this study,” said Chris Bunka, CEO of Lexaria. “Our technology was ten to twenty times faster in delivering comparable levels of nicotine into bloodstream than the peak of the concentration-matched controls and went on to far exceed their total delivery, which should provide much greater consumer satisfaction. Performance gains of this magnitude could be of great significance in enabling the oral pouch product category to offer improved nicotine satiety and effectiveness, with a goal of one day rendering pulmonary administration practices like smoking and vaping as obsolete.”

To view the full press release, visit https://cnw.fm/EnwFS

About Lexaria Bioscience Corp.

Lexaria Bioscience Corp.’s patented drug delivery technology, DehydraTECH(TM) improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce time of onset from 1 – 2 hours to minutes, and mask unwanted tastes; and is also being evaluated for orally administered anti-viral drugs, non-steroidal anti-inflammatory drugs (“NSAIDs”) and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 21 patents granted and over 50 additional patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.